Search by Drug Name or NDC

NDC 60505-6177-08 Busulfan 6 mg/mL Details

Busulfan 6 mg/mL

Busulfan is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Apotex Corp.. The primary component is BUSULFAN.

MedlinePlus Drug Summary

Busulfan injection is used to treat a certain type of chronic myelogenous leukemia (CML; a type of cancer of the white blood cells) in combination with other medications to destroy bone marrow and cancer cells in preparation for a bone marrow transplant. Busulfan is in a class of medications called alkylating agents. It works by slowing or stopping the growth of cancer cells in your body.

Related Packages: 60505-6177-08
Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Busulfan Injection

Product Information

NDC	60505-6177
Product ID	60505-6177_a0b0bc32-8fc8-8c09-04bf-6a751c60360e
Associated GPIs	21100010002020
GCN Sequence Number	063053
GCN Sequence Number Description	busulfan VIAL 60 MG/10ML INTRAVEN
HIC3	V1A
HIC3 Description	ANTINEOPLASTIC - ALKYLATING AGENTS
GCN	98813
HICL Sequence Number	003899
HICL Sequence Number Description	BUSULFAN
Brand/Generic	Generic
Proprietary Name	Busulfan
Proprietary Name Suffix	n/a
Non-Proprietary Name	busulfan
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	INJECTION
Route	INTRAVENOUS
Active Ingredient Strength	6
Active Ingredient Units	mg/mL
Substance Name	BUSULFAN
Labeler Name	Apotex Corp.
Pharmaceutical Class	Alkylating Activity [MoA], Alkylating Drug [EPC]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA210448
Listing Certified Through	n/a

Package

NDC 60505-6177-08 (60505617708)

Pricing Information	N/A
NDC Package Code	60505-6177-8
Billing NDC	60505617708
Package	8 VIAL, SINGLE-DOSE in 1 CARTON (60505-6177-8) / 10 mL in 1 VIAL, SINGLE-DOSE (60505-6177-0)
Marketing Start Date	2019-08-19
NDC Exclude Flag	N